Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

by Angela Y. Jia, Amol Narang, Bashar Safar, Atif Zaheer, Adrian Murphy, Nilofer S. Azad, Susan Gearhart, Sandy Fang, Jonathan Efron, Tam Warczynski, Amy Hacker-Prietz, Jeffrey Meyer
Published 2019-08-01

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic...

by Colin Hill, Shuchi Sehgal, Wei Fu, Chen Hu, Abhinav Reddy, Elizabeth Thompson, Amy Hacker‐Prietz, Dung Le, Ana De Jesus‐Acosta, Valerie Lee, Lei Zheng, Daniel A. Laheru, William Burns, Matthew Weiss, Christopher Wolfgang, Jin He, Joseph M. Herman, Jeffrey Meyer, Amol Narang
Published 2022-04-01

Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal...

by Jessica A. Smith, Aaron T. Wild, Aatur Singhi, Siva P. Raman, Haoming Qiu, Rachit Kumar, Amy Hacker-Prietz, Ralph H. Hruban, Ihab R. Kamel, Jonathan Efron, Elizabeth C. Wick, Nilofer S. Azad, Luis A. Diaz, Yi Le, Elwood P. Armour, Susan L. Gearhart, Joseph M. Herman
Published 2012-01-01

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy

by Zhi Cheng, MD, MPH, Lauren M. Rosati, BS, Linda Chen, MD, Omar Y. Mian, MD, PhD, Yilin Cao, MD, Marta Villafania, BS, Minoru Nakatsugawa, PhD, Joseph A. Moore, PhD, Scott P. Robertson, PhD, Juan Jackson, BS, Amy Hacker-Prietz, PA-C, Jin He, MD, PhD, Christopher L. Wolfgang, MD, PhD, Matthew J. Weiss, MD, Joseph M. Herman, MD, MS, Amol K. Narang, MD, Todd R. McNutt, PhD
Published 2018-10-01